Frequently Asked Questions: PAR-17-482 Comparative Genomics Research Program
Date: Thursday, September 13, 2018
Time: 2:00 - 4:00 p.m. Eastern
- How much funding is available for this program from NIH?
NHGRI does not have set aside funds for this program. Funding will be determined by score, available funds, and the fit with NHGRI programmatic priorities.
- What are the submission deadlines?
This PAR has three receipt dates: October 5; February 5; and June 5 through 2018-2021. This opportunity expires on January 8, 2021. Proposal resubmission deadlines are as follows: November 5; March 5; and July 5 through 2018-2020.
- How will these applications be reviewed?
Applications will be reviewed at NIH by the Genetic Variation and Evolution (GVE) standing study section with ad hoc reviewers with special expertise brought in as necessary to review submitted applications. Applications submitted to this PAR will be reviewed as a group using standard review criterion for NIH R01 awards.
- USDA has a companion funding opportunity; how does this work?
NIFA at the USDA has signed on to this funding opportunity and may choose to fund projects in their area of interest. Applications will be reviewed at NIH. Post-review, highly ranked projects may be selected for funding either by NHGRI or NIFA based on the alignment of the project proposal to the goals of the specific agency. Awards that are selected for funding by NIFA will be transferred and administered at USDA according to their rules and regulations. There is no plan for joint funding of individual proposals.
- Does this program support sequencing and/or data generation?
This program supports novel comparative approaches, methods, tools, and resources that will have broad utility. If specific data generation is required to validate the approach or method, test the tools, or complete a resource, then some data generation may be supported. We expect that, as much as possible, applicants will use existing data.
- What species/organisms are allowed under this funding opportunity? How many species is enough?
Any eukaryotic organisms are allowed if they will provide insight into how genomes function and how changes in human genomic sequence and/or organization may translate into phenotypic changes. Species selection, both in terms of number of species and the evolutionary breadth of species included, should be relevant to the question being asked and should include sufficient representation to ensure broad applicability of methods, approaches, tools, and biologically relevant findings. NHGRI is interested in projects with relevance for human health and disease; NIFA is interested in projects involving agricultural animal species that may provide insight into outcomes relevant to agriculture.
Last Updated: September 17, 2018